Global Proton Therapy Market: Trends and Opportunities (2015 Edition)
Scope of the Report The report titled “Global proton therapy Market: Trends & Opportunities (2015 Edition)” provides an in-depth analysis of the global proton therapy market with detailed analysis of market sizing and patients treated by proton therapy. The report also provides detailed market share analysis of the global proton therapy market by regions and players. In addition to proton therapy, the report also provides market analysis of the radiation therapy. The report provides detailed regional analysis of North America, Europe and Asia for the proton therapy market. Regional proton therapy market is analyzed on the basis of proton therapy installation base and patients treated by proton therapy. Regional analysis also includes currently operating clinical proton therapy facilities and upcoming clinical proton therapy facilities each in North America, Europe and Asia. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global proton therapy market has also been forecasted for the period 2015-2019, taking into consideration the previous growth patterns. The competition in global proton therapy market is stiff and dominated by the big players like IBA. Further, key players of the proton therapy market are Hitachi, Varian Medical Systems and Mitsubishi Electric is also profiled with their financial information and respective business strategies. Region Coverage • North America • Europe & Russia • Asia Company Coverage • IBA, Inc. • Hitachi Ltd. • Varian Medical Systems, Inc. • Mitsubishi Electric Group Executive Summary Global proton therapy market increased over the years and is projected to rise at a significant CAGR in the next five years i.e. 2015-2019. The upsurge in the market was due to the increased cancer incidences over the years along with the increased awareness about proton therapy among people. The major growth drivers for the market are: increase in cancer incidences, rising public awareness, low treatment cost, technological innovation and the replacement cycle. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as: high installation cost, competitive technologies and high reimbursement rates.